Vistamerica announced the approval of VistaVerde ICG in Mexico

ICG available in Mexico

ICG now approved in Mexico – Vistamerica announced the approval of VistaVerde ICG in Mexico: Available on market in October 2020

Puerto Peñasco, Sonora.  August 20, 2020.  Vistamerica S de RL is proud to announce that VistaVerde ICG has been approved by the Federal Committee for Protection from Sanitary Risks (COFEPRIS) in Mexico. Vistamerica has exclusive distribution rights for Indocyanine Green (ICG) for the entire territory of Mexico, with plans set to enter the market in October 2020.

ICG, produced by Michigan based Diagnostic Green LLC, the leading provider of trusted high-quality fluorescence pharmaceutical products, is well known and accepted by physicians worldwide. Indicated for use in determining cardiac output, hepatic function and liver blood flow, and for ophthalmic angiography, ICG is well tolerated and has an excellent safety profile.  It is routinely used by physicians during fluorescent guided surgery. 

“We are delighted to engage with such a dedicated and enthusiastic company that will ensure ICG will be available to physicians throughout Mexico”, stated Ron Clarke, VP Business Development at Diagnostic Green. 

Vistamerica cofounder and owner Catalina Markham similarly expressed, “We are excited to offer ICG in Mexico. It is quickly becoming the standard of care during fluorescent guided surgery and we are anxious to continue providing excellent service with cutting-edge products to benefit physicians and patients alike.”

For full prescribing details, contact Vistamerica. 

Vistamerica S de RL Sinaloa Avenue No. 183-3, South Center, 83550, Puerto Peñasco, Sonora, Mexico.

Office: + 52-638-38-88668, Info@vistamerica.net.

VistaVerde

Verde de Indocianina

ICG ahora aprobado en México – Vistamerica anunció la aprobación de VistaVerde ICG en México: Disponible en el mercado en octubre del 2020

Puerto Peñasco, Sonora, 20 de agosto, 2020. Vistamerica S de RL (Vistamerica) se enorgullece de anunciar que VistaVerde ICG ha sido aprobado por la Comision Federal de Protección contra Riesgos Sanitarios (COFEPRIS) en México. Vistamerica tiene los derechos exclusivos de distribución de Indocyanine Green (ICG) para todo el territorio de México, con planes para ingresar al mercado en octubre del 2020.

ICG, es producido por Diagnostic Green LLC, con sede en Michigan, proveedor líder de productos farmacéuticos de fluorescencia de alta calidad de confianza, es bien conocido y aceptado por médicos de todo el mundo. Indicado para su uso en la determinación del gasto cardíaco, la función hepática y el flujo sanguíneo hepático, y para la angiografía oftálmica, el ICG se tolera bien y tiene un excelente perfil de seguridad. Los médicos lo utilizan habitualmente durante la cirugía guiada por fluorescencia.

“Estamos encantados de colaborar con una empresa tan dedicada y entusiasta que garantizará que ICG esté disponible para los médicos en todo México”, afirmó Ron Clarke, vicepresidente de desarrollo comercial de Diagnostic Green.

La cofundadora y propietaria de Vistamerica, Catalina Markham, expresó de manera similar: “Estamos muy contentos de ofrecer ICG en México. ICG se está convirtiendo rápidamente en el estándar de atención durante la cirugía guiada por fluorescencia y estamos ansiosos por continuar brindando un servicio excelente con productos de vanguardia para beneficiar a médicos y pacientes por igual”.

Para obtener detalles completos, comuníquese a Vistamerica.

Vistamerica S de RL Avenida Sinaloa No. 183-3, Centro Sur, 83550, Puerto Peñasco, Sonora, México.

Oficina: + 52-638-38-88668, Info@vistamerica.net.

The SAGES 2020 Annual Meeting is Virtual, 11-13 August

From August 11-13, the annual SAGES event will take place virtually. Consisting of three days of live programming, educational events, workshops and networking sessions where you can virtually mingle with other SAGES members and leadership.

Not only does the SAGES Virtual event promise a jam packed itinerary, it also has a virtual exhibition area for industry and Diagnostic Green are delighted to take part. By logging onto the SAGES exhibition area here you can access useful information from Diagnostic Green on the use of Indocyanine Green in Fluorescence Guided Surgery.

We showcase a case study, from Dr. Steven Wexner, MD, Cleveland Clinic Florida on “Evaluation of Anastomotic Perfusion following Laparoscopic Anterior Resection with Coloanal Anastomosis” and extracts from the white paper “Economic Health Technology Assessment (HTA) Approach on Surgical Endoscopy Procedures using Indocyanine Green (ICG)”. All this can be found here.

Register here to enjoy three days of unmissable information from The Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 

Live Webinar: ISFGS Round Table 13th August 2020

Defining Standards in Fluorescence Guided Surgery

The International Society for Fluorescence Guided Surgery will host a round table on August 13th 2020, 9.00pm EST Time (US and Canada).

The round table will be facilitated through a live webinar and will feature a discussion from Dr. Raul Rosenthal, Dr. Fernando Dip, Dr. Michael Bouvet and Dr. Eren Berber on the standards of fluorescence guided surgery and the use of Indocyanine Green, ICG in endocrine surgery.

If you wish to register, go to the link here, spaces are limited.